Protein corona formed on the surface of nanoparticle in biological medium determines its behavior in vivo. Here, iron oxide nanoparticles containing the same core and shell, but bearing two different surface coatings, either glucose or poly(ethylene glycol), were evaluated. The nanoparticles protein adsorption, in vitro degradation, and in vivo biodistribution and biotransformation over four months, were investigated. Although both types of nanoparticles bound similar amount of proteins in vitro, the differences in the protein corona composition correlated to the nanoparticles biodistribution in vivo. Interestingly, in vitro degradation studies demonstrated faster degradation for nanoparticles functionalized with glucose, whereas the in vivo results were opposite with accelerated biodegradation and clearance of the nanoparticles functionalized with poly(ethylene glycol). Therefore, the variation in the degradation rate observed in vivo could be related not only to the molecules attached to the surface, but also with
a previously reported protocol was applied, where NPs were coated with an amphiphilic polymer shell (poly(maleic anhydride-alt-1-octadecene), PMAO). 12, 13, 14 Using this methodology, the hydrophobic backbone of the polymer intercalates with the oleic acid chains that covers the NPs core, leaving carboxylic groups exposed to the solvent. In this case, to be able to track the NPs ex vivo, they were transferred into water using the PMAO polymer previously modified with a fluorophore, 5-carboxytetramethylrhodamine (TAMRA) (NPs@PMAO, Scheme S1). 15 To provide stability in biological media, NPs@PMAO were functionalized with either glucose (NP@Glc) or PEG molecules (NPs@PEG), as those molecules have been previously demonstrated to efficiently passivate NPs surface avoiding aggregation in cell culture medium in vitro. 16, 17, 18 There is a general consensus that protein adsorption and consequently biodistribution is highly dependent on the PEG molecular weight, therefore a long PEG of 5000 Da was chosen to passivate the surface of the NP. In fact it has been described that maximal reduction in protein adsorption is found for a PEG of 5000 Da. 19 Other examples have also linked this PEG MW with the protein adsorption and consequently with the macrophage uptake. For instance, magnetic NP uptake by macrophages is higher for NPs coated with a PEG of 600 Da when compared to a PEG of 3000 Da. 20 It should be highlighted that NPs@Glc and NPs@PEG presented the same core size ( Fig. S2a) , shell structure and stability (in water, phosphate buffered saline or cell culture medium supplemented with 10% bovine serum), differing only in surface properties ( Fig. S2b and S3 ). Therefore, these NPs were perfect candidates for an in vivo behavior comparative study, as in this case the adsorption of proteins and macrophage uptake would not be associated with the size of the NPs as previously reported. 21 7
The protein amounts were semi-quantitatively assessed by applying the spectral-counting method (SpC) in order to obtain the percentage of participating proteins in the PC composition (relative abundance). The normalized SpC amounts of each protein, which were identified in the LC-MS/ MS study, were calculated by applying the following equation: 24, 25 
where NpSpCk is the normalized percentage of the spectral count for protein k, SpC is the identified spectral count, and Mw is the molecular weight (in kDa) of the protein k. This correction takes into account the protein size and evaluates the actual contribution of each protein reflecting its relative protein abundance in the protein corona ( Fig. 1b and Fig. S6 ).
Interestingly, it was shown that although both types of functionalized NPs adsorbed similar amounts of proteins in vitro, NPs@Glc adsorbed more proteins considered opsonins (e.g. complement proteins, apolipoproteins). Indeed, a clear difference can be seen in the enrichment of complement components, which promotes clearance of NPs via interaction with macrophage complement receptors ( Figure S6(a) ). 26 In fact the relative abundance is two times higher for NPs@Glc than for NPs@PEG. Fibronectin, also enriched in the PC of NPs@Glc when compared to the PC of NPs@PEG, has been also associated with an uptake by Kupffer cells. 27 Further, specific proteins considered opsonins (coagulation factor XI, mannose-binding protein C, C4b and fibrinogen) were only found in the PC of NPs@Glc. On the other hand, the relative abundance of proteins belonging to the coagulation and apolipoproteins group were comparable ( Figure S6(b-c) ). Among all detected acute phase proteins, NPs@PEG were found to bind more 8 α-2-HS-glycoprotein than NPs@Glc ( Figure S6(d) ). This protein has been described as a negative acute phase reactant with strong analogy to albumin, therefore, it is expected that it will act similarly, promoting elongation of NP circulation in the blood. 27 Lastly, the corona of NPs@PEG was more enriched in albumin (dysopsonin), and other proteins such as kininogen that are associated with NPs covered with a high density of PEG. 21 The enrichment of other components such as clusterin that is thought to be a "don't-eat-me" protein has been found to be similar in both coronas. 28 Although the precise effect of PC composition on NP fate in vivo remains unclear, proteins considered opsonins are thought to enhance recognition and uptake of NPs by macrophages resulting in their accumulation in the organs of mononuclear phagocyte system (MPS), mainly in the liver and spleen. 29 Conversely, dysopsonins increase the half-life of molecules in the blood. 27 Page 8 of 44
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In vitro degradation study
In order to investigate if PC may be implicated in the degradation process, it was decided to use the unfunctionalized NPs, covered just with the polymer (NPs@PMAO) for the in vitro degradation study. The PC of those NPs is composed of a much higher amount of proteins than the one of the NPs@Glc or NPs@PEG (Fig. 1a ), therefore it was supposed that the effect on the degradation should be more pronounced. NPs@PMAO with and without formed PC (NPs@PMAO-PC and NPs@PMAO, respectively) were incubated in a medium mimicking intracellular lysosomal environment (pH 4.7, 20 mM citrate) 30 or in water (control). Afterwards,
NPs were analyzed using transmission electron microscopy (TEM) and alternating current (AC) magnetic measurements. Whereas the first technique allows visual analysis of degradation process, AC magnetic measurements especially through the analysis of the out-of-phase susceptibility (χ″(T)) profile, constitute a powerful tool for both detection (see NPs biodistribution 72 h post-injection section) and over time biotransformation studies. The reduction of the χ″(T) maximum height, when plotted per mass of sample, is an indicator of the decrease of the NPs concentration in a given sample ( Fig. 2a ). 31 The shift of the χ″(T) maximum location towards lower temperatures indicates the transformation of the iron core ( Fig. 2b ).
Although there are other parameters that may influence the location in temperature of the χ″(T) maximum, in this case, the main factor associated to this transformation is the reduction of the particle size due to the degradation process. 32, 33 Page 10 of 44
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ACS Applied Materials & Interfaces   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57 TEM observations showed that NPs@PMAO incubated in the lysosomal medium were degraded, in contrast to their PC-counterparts or the samples in water, that remained unalterable ( Fig. 3a ). Magnetic measurements ( Fig. 3b ) confirmed those results as the scaled χ″(T) maximum of the NPs@PMAO incubated in the lysosomal medium was clearly shifted towards lower temperatures on the contrast to other samples. Therefore, these results unambiguously demonstrate that the presence of PC on the surface of NPs provides protection against NP core degradation in the lysosomal medium. Detailed investigation of the degraded NPs showed that NP core, although partially degraded, still maintained the crystalline structure. The dissolved iron ions were retained around NP core as a ring, (Fig. 3c, d ) most probably forming coordination complexes with the carboxylic groups of the polymer (Fig. S7 ). The impact of different accessibility of iron chelating agents to the iron oxide crystal on the degradation kinetics has been already highlighted. 34, 35 In this study nanocubes coated with PEG-gallol directly anchored to the iron oxide surface were found to degrade more rapidly and dissolve completely on the contrast to the nanocubes embedded in an amphiphilic polymer shell similar to the one used here.
This was explained by the fact that the polymer chains attached to discrete sites of the crystal surface could leave more access to the small citrate ions provoking accelerated degradation. NPs@PEG influence on the degradation rate, both NPs types with PC were incubated in a lysosomal mimicking medium as described before. It was found by TEM that in only ten days of incubation, a significant part of the NPs@Glc was totally degraded losing their original shape, while most of the NPs@PEG remained unaffected ( Fig. 4a ). Those results were also confirmed by the AC magnetic measurements (Fig. 4b ).
Here the signal for NPs@Glc incubated in acidic medium was clearly moved towards lower temperatures on the contrary to the NPs@PEG one, indicating that the core of the first type of NPs has been modified. Those results are quite interesting, as both NPs types although are composed of exactly the same core and shell structure ( Fig. S2a ), present diverse degradation profiles in vitro. These results can be explained by the fact that as already described in the literature, 36 the capping agents (in this case glucose and PEG molecules used for the functionalization), influence on the different accessibility to the iron surface. In fact, also in this study we found that the NPs@Glc and NPs@PEG not bearing their PCs degraded with different kinetics in vitro ( Fig. S8 ). However, the NPs@Glc without the adsorbed PC were found to be degraded to a greater extent than the same NPs bearing PC. By comparing TEM micrographs, it can be noticed that although some part of NPs@Glc-PC was degraded in the acidic environment, another part of those NPs preserved quite good their original morphology ( Fig. 4a left upper corner of the NPs@Glc-PC/lysosomal medium micrograph). On the other hand, almost all NPs@Glc incubated in the lysosomal medium were found degraded. Concordantly, the scaled χ″(T) maximum of the NPs@Glc-PC incubated in the acidic medium was shifted only to 90 K, whereas the same signal but for the NPs@Glc incubated in the acidic medium reached 40 K. Therefore, also in this case it was found, that PC can provide at least partial protection against degradation of the NP core.
Interestingly, recent studies indicate that the accessibility to the iron surface may not only depend on the capping agent, but also on the composition of PC. In fact, proteins attached to the NPs can be digested in the lysosomal environment with different kinetics. 7 It has been suggested that proteins of lower molecular weight would be degraded slower than others with higher molecular weights. 37 Taking into account that both the attached molecule and the PC have an effect in the biodegradation in vitro, NPs@Glc and NPs@PEG were administrated in vivo to verify the biodistribution and biodegradation of NPs.
In vivo biodistribution and toxicity study
Despite the fact that IONPs are considered biocompatible, their safety may vary depending on different factors, such as: composition, physicochemical properties, route of administration or 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 dose range, and need to be revised on in vivo level, especially in the context of the little correlation that has been found between in vitro and in vivo studies. 38, 39 Therefore, NPs@Glc and NPs@PEG biodistribution and toxicity at short (72 h) and long term (four months) were analyzed employing 6-weeks old Swiss male and female individuals. The injected dose (0.1 mmol Fe/kg animal) was similar to the dose of iron used as contrast agent in clinical magnetic resonance imaging. 40, 41 Intravenous administration of both types of NPs did not affect animal body weight either in short finding no significant variation with respect to control values ( Fig. S13 and S14). Note that the results were the same for male and female animals in contrast to what it has been reported in other studies, where the toxicity induced by PEG-coated gold NPs was different depending on the animal gender. 42 The rest of studies were only performed on female animals.
NPs biodistribution 72 h post-injection
As the IONPs were coated with a polymer shell modified with a fluorescent dye, their localization in selected organs ex vivo could be performed by examination of longitudinal tissue sections using fluorescence microscopy. 72 h after the administration of NPs@Glc, an intense and abundant fluorescence signal evidenced NPs accumulation mainly in the liver and spleen ( Fig. 5 ). Whereas in the liver NPs were distributed homogenously throughout the tissue, in the spleen they were primarily observed in the red pulp and/or marginal zone. 43 Also, a scarce signal 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 of NPs@Glc was found in the kidneys (Fig. 5 ). Interestingly, 72 h after administration NPs@PEG were detected in all examined organs ( Fig. 5 and Fig. S15 ). The highest NPs@PEG accumulation was observed in the liver and spleen with homogenous distribution in both organs ( Fig. 5 ) but also a quite significant amount was found in the reproductive organs, in both females and males. NPs@PEG in lower quantities were also localized in the kidneys, lungs, heart and thymus ( Fig. S15 ). Of note, the disparate biodistribution profile for both NPs types could be specially appreciated in the spleen, where NPs@Glc were accumulated only in the red pulp and/or marginal zone, while NPs@PEG were homogenously distributed in the tissue. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58 59 60 Those results were confirmed by the AC magnetic measurements through the analysis of the outof-phase susceptibility (χ″(T)) profile, which allows to specifically identify and quantify the presence of superparamagnetic material, such as IONPs in biological matrices. In this case other iron-containing species (e.g. hemoglobin or ferritin) that are commonly present in tissue samples, do not contribute to the χ″(T) signal. 44 This is a huge advantage over traditional methods for
IONPs detection, such as elemental analysis or Prussian Blue staining, which fail to accurately quantify very small amount of iron from NPs due to a substantial amount of endogenous iron. As already suggested by the fluorescence microscopy, magnetic measurements confirmed that NPs@Glc were abundantly accumulated in the liver and spleen (Fig. 6a ), whereas NPs@PEG were found in all analyzed organs, including lungs and heart ( Fig. 6b ). 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56 Additionally, the height of the out-of-phase susceptibility per mass of the tissue sample acts as a surrogate of the amount of NPs, therefore the amount of Fe in the tissue can be calculated ( Table   1 ). The abundant accumulation of NPs@Glc in the liver and spleen (3.8 and 1.7 higher in comparison with NPs@PEG, respectively, Table 1 ), suggests that NPs@Glc were rapidly recognized by macrophages and cleared from the blood, disabling accumulation in other organs.
This hypothesis of fast clearance of NPs@Glc from the bloodstream by macrophages is supported by the in vitro studies performed with RAW 264.7 macrophages ( Fig. S16 ), in which NPs@Glc and NPs@PEG bearing PC were incubated in serum-free conditions to avoid unspecific adsorption of proteins. If the proteins (i.e. opsonins) adsorbed in the PC are recognized by macrophages, are in the correct orientation and not masked with other proteins, they should be able to bind to macrophage receptors and be uptaken. 45 Just two hours after 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 incubation we found that while NPs@PEG were not uptaken by the macrophages, NPs@Glc were highly uptaken. This confirms the results of the in vivo biodistribution, and has to be related with the different enrichment of proteins in each PC (as the amount of adsorbed proteins is similar), although their different orientation cannot be ruled out. Although coating of NPs with glucose significantly decreases the unspecific adsorption of model proteins 46 and increases NPs uptake by cancerous cells in vitro (due to their elevated metabolic growth rate 47 and/or expression of glucose transporters), 48, 49 in vivo studies demonstrate removal from the blood within an hour, 50 scarce accumulation in the tumor tissue and rapid uptake by the liver and spleen, 51 probably as a result of PC impact.
Interestingly, it has to be highlighted that the composition of PC found in vitro where the ratio between albumin/complement proteins was nearly two times higher for NPs@PEG compared with NPs@Glc, positively correlated with the NPs behavior in vivo 72 h after injection. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 Heart -0,003
NPs biodistribution four months post-injection
Once NPs are cleared from the blood and accumulated in organs, they undergo biotransformation processes, which may result in their degradation, assimilation and therefore elimination or persistence. Evaluation of NP behavior in a long time frame is necessary to encompass the whole NP lifecycle in vivo and predict potential exposure risk. In this case, AC magnetic measurements corroborated the results obtained from the fluorescence examination of tissue sections ( Fig. S17 and S18) showing that four months after the injection NPs@Glc were still present in the liver and spleen, whereas NPs@PEG were only present in the liver (Fig. 7) . From the rest of the organs, both NPs types were cleared. From the relative height of the χ″(T) peak at four months, which was always smaller than the peak at 72 h (Fig 7. and Table 2 ), it was demonstrated that there was a general trend of NPs clearance in both liver and spleen. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56 The liver showed 23 times fewer NPs@Glc compared to 72 h, while the spleen showed only three times signal reduction. That evidenced that NPs@Glc were cleared more efficiently from the liver than from the spleen. In the case of NPs@PEG, although the maximum χ″(T) for the liver decreased nearly 18 times when compared to 72 h signal, it was still present, whereas for 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 the spleen it almost disappeared. It is surprising that the degradation process in this case was faster in the spleen than in the liver, more particularly when the concentration in the spleen 72 h post-injection of NPs@PEG was 4.7 times higher compared to the liver. 
In summary, both NPs types showed, apart from diverse biodistribution pattern, different clearance rate. Whereas NPs@PEG were more efficiently cleared from the spleen, NPs@Glc clearance was more dynamic in the liver. In fact, faster clearance of NPs from liver has been described for many NPs types irrespectively of their core or coating. 8, 52, 53 This is explained by the fact that the concentration per gram of organ is always higher in the spleen than in the liver.
Therefore it is thought that the spleen degradation capacity may be saturated. However, this assumption finds a confirmation here only in the case of NPs@Glc and not NPs@PEG, as the latter were almost totally cleared from the spleen (Fig. 7) . 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 To characterize the biodegradation of the NPs, the shift in temperature of the scaled χ″(T) maxima was studied (Fig. 8 ). In the case of NPs@PEG, there was a clear shift of the χ″(T) maximum from 60 K to 24 K over time (Fig. 8a ). This indicates that most of the NPs@PEG in the liver underwent a transformation that could be associated with a reduction of NPs size, disaggregation, or both. In the case of the liver from the animals that received the NPs@Glc, the signal was broader, in particular towards lower temperatures (Fig. 8b) . This could be interpreted as a fraction of the NPs being partially degraded while another fraction still remains not modified. In the spleen, NPs@Glc were scarcely transformed, as the maximum was only slightly shifted towards lower temperatures (Fig. 8c ). 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56 If in the spleen the core of the NPs@Glc remained barely unmodified during the four months, the decrease of NPs concentration could be related to: i) a different degradation mechanism than in the liver, i.e. a small fraction of NPs are being degraded while the vast majority is unaffected; ii) an excretion of the NPs from the tissue, reducing the amount of NPs but not degrading them.
As seen before, the PC of NP@Glc was enriched in opsonins when compared to the PC of NP@PEG that was more enriched in albumin. The fact that proteins from the PC can be degraded in lysosomes has been previously described. 54 Further, Ma et al. 7 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 suggesting that each heterostructure has its own kinetics of degradation. Similarly, when analyzing the biodegradation of iron oxide nanocubes, it was shown that some of them were found degraded already 14 days after injection, where others were untouched. 34 The irregular petal-resemble shape of the heterostructures or unequal polymer shell coverage on the nanocubes edges may facilitate a different cellular medium penetration, leading to inconsistent degradation of the nanomaterial. However, these factors cannot be taken into account in the present study as interestingly differences in degradation have been observed between two NPs containing exactly the same core and polymer shell and differentiated only by the subsequent surface modification. NPs@Glc were found to be tightly packed in the lysosomes of the spleen and liver cells on the contrary to NPs@PEG ( Fig. 9 and Fig. S19-20) . This could ultimately affect the degradation kinetics due to an unequal access of enzymes to the core. 6 Although further research is needed to fully unravel these issues, we have demonstrated that in vivo studies are absolutely necessary in order to understand the long term degradation of NPs. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57 58 59 60 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 CONCLUSIONS Before employing NPs in vivo, the parameters that affect their fate and degradation should be controlled. Using two NPs with identical core but different surface coating, we have shown that biodistribution and degradation over four months are completely different. In this case, a direct correlation between the PC composition in vitro and the fate of NPs in vivo was established.
The fact that in vivo
Moreover, it has been demonstrated that two parameters govern the NPs degradation in vitro: the surface coating, which influences the degradation rate, and the PC, which protects against NPs core degradation in acidic conditions.
In vivo, it has been shown that NPs@PEG core suffered a faster degradation over time than
NPs@Glc, in both liver and spleen. Interestingly, the degradation kinetics was different in the liver and spleen, depending on the NPs type. Although the degradation rate could be related to overlapping factors, these differences can still have their primary origin in the PC, whose composition drives NPs fate and may also influence on the degradation rate in the lysosomes.
For the first time it has been demonstrated that the biodegradation process is not only related with the NPs core and shell, but also with the surface coating, and therefore the associated PC.
Further research will increase our understanding of NPs biodegradation associated to PC, opening the way to adopt strategies to control NPs behavior on the long-term frame.
METHODS

Chemicals.
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In vitro degradation study of NPs. NPs at equals concentrations (0,1 mg/mL; 46 µg of Fe) were incubated in lysosomal mimicking medium containing citric acid 4.4 mM and sodium citrate tribasic dihydrate 5.6 mM pH 4.7 at room temperature. NPs@Glc and NPs@PEG were incubated for ten days, whereas NPs@PEG for two months. As a control NPs were left for the same period 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 injected. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 The magnetic characterization was performed in a Quantum Design MPMS-XL and MPMS-5S SQUID magnetometers equipped with an AC (Alternating current) magnetic susceptibility option. The measurements were performed with AC amplitude of 0.41 Oe, in the temperature range between 2 and 300 K and at a frequency of 11 Hz.
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